Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Kobayashi Pharmaceutical Co., Ltd. KBYPF

Set alert

Price alert · KBYPF

All alert types
39.47 USD 0.00 0.00%

At close · Oct 29

39.47 Day range 40.76
34.05 52-week range 39.47
YTD
+14.01%
1 year
+14.01%
Open
40.76
Prev close
39.47
Mkt cap
2.93B
Vol
300
Avg vol
4
EPS
0.14
P/E
281.93
More statistics
Low
39.47
High
40.76
Earnings
Nov 5, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for KBYPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

8.98 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 2
  • Return on Equity 2
  • Return on Assets 2
  • Debt / Equity 5
  • P/E 1
  • P/B 3

Valuation

P/E 110×
FY 2016: 28.2×FY 2017: 24.6×FY 2018: 21.1×FY 2019: 28.9×FY 2020: 27.3×FY 2021: 36.3×FY 2022: 27.9×FY 2023: 29.1×FY 2024: 43.5×FY 2025: 110×
FY 2016 5y median 36.3× FY 2025
P/S 2.4×
FY 2016: 2.8×FY 2017: 2.5×FY 2018: 2.3×FY 2019: 3.3×FY 2020: 3.5×FY 2021: 4.6×FY 2022: 3.4×FY 2023: 3.4×FY 2024: 2.6×FY 2025: 2.4×
FY 2016 5y median 3.4× FY 2025
P/B 1.9×
FY 2016: 3.0×FY 2017: 2.5×FY 2018: 2.3×FY 2019: 3.2×FY 2020: 2.9×FY 2021: 3.7×FY 2022: 2.8×FY 2023: 2.9×FY 2024: 2.1×FY 2025: 1.9×
FY 2016 5y median 2.8× FY 2025
P/FCF 32.7×
FY 2016: 24.4×FY 2017: 20.4×FY 2018: 23.4×FY 2019: 36.2×FY 2020: 26.4×FY 2021: 39.3×FY 2022: 35.6×FY 2023: 123×FY 2024: -28.5×FY 2025: 32.7×
FY 2016 5y median 35.6× FY 2025
EV/EBITDA 14.5×
FY 2016: 16.7×FY 2017: 12.4×FY 2018: 10.4×FY 2019: 15.5×FY 2020: 14.9×FY 2021: 20.2×FY 2022: 14.5×FY 2023: 15.5×FY 2024: 17.7×FY 2025: 14.5×
FY 2016 5y median 15.5× FY 2025
EV/Sales 2.1×
FY 2016: 2.5×FY 2017: 2.1×FY 2018: 1.8×FY 2019: 2.9×FY 2020: 3.0×FY 2021: 4.0×FY 2022: 2.8×FY 2023: 3.0×FY 2024: 2.3×FY 2025: 2.1×
FY 2016 5y median 2.8× FY 2025
FCF Yield 3.1%
FY 2016: 4.1%FY 2017: 4.9%FY 2018: 4.3%FY 2019: 2.8%FY 2020: 3.8%FY 2021: 2.5%FY 2022: 2.8%FY 2023: 0.8%FY 2024: -3.5%FY 2025: 3.1%
FY 2016 5y median 2.5% FY 2025

Profitability

Gross Margin 47.9%
FY 2016: 58.9%FY 2017: 60.9%FY 2018: 61.6%FY 2019: 61.5%FY 2020: 56.6%FY 2021: 57.2%FY 2022: 55.5%FY 2023: 55.6%FY 2024: 52.9%FY 2025: 47.9%
FY 2016 5y median 55.5% FY 2025
Operating Margin 9.0%
FY 2016: 12.4%FY 2017: 14.6%FY 2018: 15.7%FY 2019: 15.7%FY 2020: 17.2%FY 2021: 16.8%FY 2022: 16.0%FY 2023: 14.9%FY 2024: 15.0%FY 2025: 9.0%
FY 2016 5y median 15.0% FY 2025
Net Margin 2.2%
FY 2016: 10.0%FY 2017: 10.1%FY 2018: 10.8%FY 2019: 11.4%FY 2020: 12.8%FY 2021: 12.7%FY 2022: 12.0%FY 2023: 11.7%FY 2024: 6.1%FY 2025: 2.2%
FY 2016 5y median 11.7% FY 2025
ROE 1.7%
FY 2016: 10.7%FY 2017: 10.3%FY 2018: 10.8%FY 2019: 11.1%FY 2020: 10.5%FY 2021: 10.1%FY 2022: 10.1%FY 2023: 9.9%FY 2024: 4.7%FY 2025: 1.7%
FY 2016 5y median 9.9% FY 2025
ROIC 6.7%
FY 2016: 8.9%FY 2017: 9.8%FY 2018: 10.6%FY 2019: 10.4%FY 2020: 9.9%FY 2021: 9.2%FY 2022: 9.4%FY 2023: 9.0%FY 2024: 8.2%FY 2025: 6.7%
FY 2016 5y median 9.0% FY 2025
ROA 1.3%
FY 2016: 7.6%FY 2017: 7.2%FY 2018: 7.8%FY 2019: 8.2%FY 2020: 8.1%FY 2021: 7.8%FY 2022: 7.8%FY 2023: 7.6%FY 2024: 3.8%FY 2025: 1.3%
FY 2016 5y median 7.6% FY 2025

Growth (YoY)

Revenue 0.2%
FY 2016: 11.3%FY 2017: 2.7%FY 2018: 6.8%FY 2019: 0.3%FY 2020: -10.4%FY 2021: 3.1%FY 2022: 7.1%FY 2023: 4.3%FY 2024: -4.5%FY 2025: 0.2%
FY 2016 FY 2025
Operating Income -40.2%
FY 2016: 3.6%FY 2017: 21.2%FY 2018: 14.7%FY 2019: 0.3%FY 2020: -1.6%FY 2021: 0.5%FY 2022: 2.3%FY 2023: -3.3%FY 2024: -3.6%FY 2025: -40.2%
FY 2016 FY 2025
EPS (diluted) -63.7%
FY 2016: 15.6%FY 2017: 5.2%FY 2018: 13.4%FY 2019: 7.1%FY 2020: 0.7%FY 2021: 2.7%FY 2022: 2.9%FY 2023: 3.3%FY 2024: -49.5%FY 2025: -63.7%
FY 2016 FY 2025
Free Cash Flow 180.3%
FY 2016: 71.8%FY 2017: 8.4%FY 2018: -14.8%FY 2019: -6.3%FY 2020: 29.8%FY 2021: -8.1%FY 2022: -14.0%FY 2023: -69.5%FY 2024: -421.1%FY 2025: 180.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 2.7×FY 2017: 2.6×FY 2018: 2.8×FY 2019: 3.0×FY 2020: 3.3×FY 2021: 3.6×FY 2022: 3.3×FY 2023: 2.8×FY 2024: 3.1×FY 2025: 2.5×
FY 2016 5y median 3.1× FY 2025
Quick Ratio 2.1×
FY 2016: 2.5×FY 2017: 2.4×FY 2018: 2.6×FY 2019: 2.8×FY 2020: 3.0×FY 2021: 3.3×FY 2022: 3.0×FY 2023: 2.4×FY 2024: 2.6×FY 2025: 2.1×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -2.6×
FY 2016: -2.6×FY 2017: -2.4×FY 2018: -2.5×FY 2019: -2.4×FY 2020: -2.6×FY 2021: -3.1×FY 2022: -3.0×FY 2023: -2.1×FY 2024: -2.3×FY 2025: -2.6×
FY 2016 5y median -2.6× FY 2025
Interest Coverage 530×
FY 2016: 0.0×FY 2017: 603×FY 2018: 751×FY 2019: 1318×FY 2020: 1235×FY 2021: 1448×FY 2022: 1482×FY 2023: 889×FY 2024: 888×FY 2025: 530×
FY 2016 5y median 889× FY 2025

Dividends

Dividend Yield 1.9%
FY 2016: 1.2%FY 2017: 1.1%FY 2018: 1.3%FY 2019: 1.0%FY 2020: 1.1%FY 2021: 0.9%FY 2022: 1.2%FY 2023: 1.2%FY 2024: 1.7%FY 2025: 1.9%
FY 2016 5y median 1.2% FY 2025
Payout Ratio 209.3%
FY 2016: 34.1%FY 2017: 27.4%FY 2018: 26.7%FY 2019: 27.9%FY 2020: 30.1%FY 2021: 31.7%FY 2022: 32.5%FY 2023: 35.5%FY 2024: 74.6%FY 2025: 209.3%
FY 2016 5y median 35.5% FY 2025

Annual · latest fiscal year ends 2025-12-31